Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
+4,884
New +$218K 0.01% 1057
2022
Q3
Sell
-13,109
Closed -$656K 710
2022
Q2
$656K Buy
+13,109
New +$696K 0.08% 236
2022
Q1
Sell
-10,404
Closed -$521K 681
2021
Q4
$521K Buy
+10,404
New +$515K 0.06% 291
2017
Q3
Sell
-23,711
Closed -$1.14M 327
2017
Q2
$1.14M Buy
23,711
+9,901
+72% +$473K 0.35% 97
2017
Q1
$558K Sell
13,810
-212
-2% -$8.99K 1.25% 40
2016
Q4
$567K Sell
14,022
-122
-0.9% -$4.81K 0.99% 51
2016
Q3
$540K Buy
+14,144
New +$568K 1.21% 36

Other funds holding SNY

StoneX Group's SNY Position: Q2 2026 in Review

StoneX Group opened a new position in Sanofi (SNY) in Q2 2026: 4,884 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #1057 among its holdings. This is a return to the name: StoneX Group previously reported a position in SNY as recently as Q2 2022.

StoneX Group first reported a position in SNY in Q3 2016 and has held it in 7 quarters since. The position peaked at $1.14M in Q2 2017. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • StoneX Group held 4,884 shares of Sanofi worth $215K as of Q2 2026.
  • Sanofi was a new StoneX Group position in Q2 2026.
  • Sanofi made up 0.01% of StoneX Group's portfolio in Q2 2026, its #1057 holding.
  • StoneX Group first reported a position in Sanofi in Q3 2016 and has held it in 7 quarters since.
  • StoneX Group's Sanofi position peaked at $1.14M in Q2 2017.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.